IQVIA Solutions Belgium
0400.502.211 · rovalta.com · 26/09/2026
IQVIA Solutions Belgium
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOIQVIA Solutions Belgium is a Private limited company incorporated in 1968. Its main activity is: Market research and public opinion polling. Its registered office is in Zaventem. It employs on average 134,8 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0400.502.211
- Incorporation
- 01/01/1968
- Legal form
- Private limited company
- Registered office
- Da Vincilaan 7
1930 Zaventem · FlandreSee on map - Contributed capital
- 7 062 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 134,8 ETP
Joint committees (2)
- 200
- 218
Financials
Source · NBB, 21 filingsTrend over 11 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 33,1 M € | +4.0% | 31,8 M € | +8.7% | 29,3 M € | +64.9% | 17,8 M € | -7.2% | 19,2 M € |
| EBITDA | 4,9 M € | +3.2% | 4,7 M € | -7.7% | 5,1 M € | +119% | 2,3 M € | +6.9% | 2,2 M € |
| Operating result | 2,7 M € | +3.5% | 2,6 M € | -18.8% | 3,3 M € | +78.4% | 1,8 M € | +749% | 215,2 k € |
| Net result | 1,8 M € | +85.4% | 985 k € | -58.0% | 2,3 M € | +161% | 897,6 k € | +270% | -529 k € |
| Balance sheet | |||||||||
| Equity | 17,2 M € | +11.9% | 15,4 M € | +6.9% | 14,4 M € | +19.5% | 12 M € | +8.1% | 11,1 M € |
| Total assets | 78,1 M € | +6.0% | 73,7 M € | -6.6% | 78,9 M € | +20.9% | 65,2 M € | +175% | 23,7 M € |
| Cash | 4,5 M € | +68.0% | 2,7 M € | +410% | 521,5 k € | +27.9% | 407,7 k € | -1.1% | 412,2 k € |
| Debts | 56,9 M € | +3.6% | 54,9 M € | -11.9% | 62,4 M € | +18.3% | 52,7 M € | +347% | 11,8 M € |
| Other | |||||||||
| Workforce | 134,8 ETP | -2.7% | 138,5 ETP | -0.7% | 139,5 ETP | +77.7% | 78,5 ETP | +9.0% | 72,0 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20252 active · 40 ended
Active mandates
Ended mandates
Other companies at this address
Da Vincilaan 7 1930 Zaventem| Company | CBE no. |
|---|---|
FORCEA● Active | 0883.520.342 |
IM ASSOCIATES● Active | 0464.554.477 |
IQVIA Cancer Research● Active | 0763.914.095 |
| 0459.151.577 | |
Orifarm Healthcare● Active | 0755.731.948 |
REDPHARMA● Active | 0824.819.011 |
TAKEDA BELGIUM● Active | 0403.054.202 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 13/07/2026 | 23/07/2025 | 10/07/2024 | 14/07/2023 | 20/07/2022 | 04/08/2021 |
| General meeting | 10/07/2026 | 09/07/2025 | 10/07/2024 | 12/07/2023 | 13/07/2022 | 12/07/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 21 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 10/07/2026 | 13/07/2026 | Dutch | |
| Full model | 31/12/2024 | 09/07/2025 | 23/07/2025 | Dutch | |
| Full model | 31/12/2023 | 10/07/2024 | 10/07/2024 | Dutch | |
| Full model | 31/12/2022 | 12/07/2023 | 14/07/2023 | Dutch | |
| Full model | 31/12/2021 | 13/07/2022 | 20/07/2022 | Dutch | |
| Full model | 31/12/2020 | 12/07/2021 | 04/08/2021 | Dutch | |
| Full model | 31/12/2019 | 18/08/2020 | 19/08/2020 | Dutch | |
| Full model | 31/12/2018 | 24/06/2019 | 09/07/2019 | Dutch | |
| Full modelCorrection | 31/12/2017 | 27/02/2019 | 15/03/2019 | Dutch | |
| Full model | 31/12/2017 | 15/06/2018 | 20/06/2018 | Dutch | |
| Full model | 31/12/2016 | 25/08/2017 | 28/08/2017 | Dutch | |
| Full model | 31/12/2015 | 20/07/2016 | 12/08/2016 | Dutch | |
| Full model | 31/12/2014 | 10/07/2015 | 23/07/2015 | Dutch | |
| Full model | 31/12/2013 | 14/11/2014 | 10/12/2014 | Dutch | |
| Full model | 31/12/2012 | 13/12/2013 | 17/12/2013 | Dutch | |
| Full model | 31/12/2011 | 13/08/2013 | 17/09/2013 | Dutch | |
| Full model | 31/12/2010 | 07/06/2013 | 06/08/2013 | Dutch | |
| Full model | 31/12/2009 | 21/12/2012 | 11/03/2013 | Dutch | |
| Full model | 31/12/2008 | 23/12/2011 | 07/11/2012 | Dutch | |
| Full model | 31/12/2007 | 20/10/2009 | 13/11/2009 | Dutch | |
| Full model | 31/12/2006 | 21/12/2007 | 18/02/2008 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 25 M€ and 50 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20252 active · 40 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates01/09/2026Herbenoeming van de commissaris
- Capital / shares13/07/2026STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - KAPITAAL - AANDELEN
- Mandates21/05/2024ONTSLAGEN - BENOEMINGEN
- Mandates01/09/2023ONTSLAGEN - BENOEMINGEN
- Restructuring19/06/2023DOEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring21/04/2023RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Mandates21/02/2023ONTSLAGEN - BENOEMINGEN
- Mandates07/10/2021ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20251,8 M €↑
- 2024Annual accounts 2024985 k €↓
- 2023Annual accounts 20232,3 M €↑
- 12/07/2023nominationMazars Bedrijfsrevisoren - Reviseurs D' Entreprises — commissaris
- 12/07/2023nominationPatrick Van Dooren — gevolmachtigde
- 12/07/2023nominationLisbeth Van Eeckhoudt — gevolmachtigde
- 12/07/2023nominationHervé Akpo — gevolmachtigde
- 12/07/2023nominationEmmanuel Vanderhaegen — gevolmachtigde
- 12/07/2023nominationLieve Porrez — gevolmachtigde
- 12/07/2023nominationDirk De Greef — gevolmachtigde
- 12/07/2023nominationJan-Frederik Keustermans — bijzondere volmacht
- 12/07/2023nominationKasper Theunissen — bijzondere volmacht
- 12/07/2023nominationMichiel De Wolf — bijzondere volmacht
- 12/07/2023nominationTom Vanderhaegen — bijzondere volmacht
- 12/07/2023nominationTalitha Crabbe — bijzondere volmacht
- 01/02/2023nominationEmmanuel Vanderhaegen — bestuurder
- 01/02/2023reconductionClément Vanthoumhout — bestuurder
- 2022Annual accounts 2022897,6 k €↑
- 2021Annual accounts 2021-529 k €↓
- 2017Name changeIQVIA Solutions Belgium
- 2014Annual accounts 2014326,9 k €↓
- 2013Annual accounts 2013729,5 k €↑
- 2012Annual accounts 2012674,8 k €↓
- 2011Annual accounts 2011700,5 k €↑
- 2010Annual accounts 2010-1,1 M €↑
- 2007Annual accounts 2007-2,1 M €
- 2007Name changeIMS HEALTH
- 01/01/1968IncorporationPrivate limited company